Key facts
- This page summarizes Brian di Donato's Form 3 filing for Immunocore Holdings plc (IMCR).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 02 Jan 2024, 16:41.
Brian di Donato - 02 Jan 2024 Form 3 Insider Report for Immunocore Holdings plc (IMCR)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- IMCR
- Reported as of
- 02 Jan 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 02 Jan 2024, 16:41:18 UTC
- Next SEC filing
- 21 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Di Donato
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian di Donato filed Form 3 for Immunocore Holdings plc (IMCR) on 02 Jan 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMCR
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,230
- Date
- 02 Jan 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMCR
holding
Derivative
Employee Share Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 56,250
- Exercise price
- $17.46
- Footnotes
- F1
IMCR
holding
Derivative
Employee Share Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 127,152
- Exercise price
- $26.00
- Footnotes
- F2
IMCR
holding
Derivative
Employee Share Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 67,977
- Exercise price
- $24.66
- Footnotes
- F3
IMCR
holding
Derivative
Employee Share Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 67,949
- Exercise price
- $64.53
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The original option award was for 300,000 shares. 25% of the shares subject to the option award vested on July 1, 2021, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Footnote F2
The original option award was for 406,884 shares. 25% of the shares subject to the option award vested on February 4, 2022, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Footnote F3
The original option award was for 120,843 shares. 25% of the shares subject to the option award vested on February 16, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Footnote F4
25% of the shares subject to the option award shall vest on February 16, 2024, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney